PRWeb.com Press Release Feed - PRWeb Press Release Account Feed

Selexis SA CSO to Speak at the Human Antibodies and Hybridomas 2011 Conference

Wed, 31 Aug 2011 07:00:00 GMT

Dr. Pierre-Allain Girod to Present on Data on Engineering CHO Cell Lines for Enhanced Production of Monoclonal Antibodies and Fc:Fusion Proteins

(PRWeb August 31, 2011)

Read the full story at http://www.prweb.com/releases/fc_fusion_protein/antibodies_selexis/prweb8753991.htm

Selexis SA to Present and Partner at the BioPharm America 2011 Partnering Conference

Tue, 30 Aug 2011 07:00:00 GMT

Andrew Sandford, will present, “From Candidate Discovery to Product Development: Improving Drug Discovery with Selexis' Next Generation of SUREtechnologies” on Thursday, September 8, 2011 at 1:45 PM at the BioPharma America Partnering Conference being held February 7-9, 2011, at the Westin Boston Waterfront in Boston, Massachusetts.

(PRWeb August 30, 2011)

Read the full story at http://www.prweb.com/releases/drug_discovery/selexis/prweb8753206.htm

CSL Limited Signs Commercial License Agreement with Selexis SA

Tue, 26 Jul 2011 11:00:00 GMT

CSL Limited will use Selexis Technologies for Development of Therapeutic Antibody

(PRWeb July 26, 2011)

Read the full story at http://www.prweb.com/releases/therapeutic_antibody/phase_i_clinical/prweb8663940.htm

Selexis CEO Elected to Board of Affitech A/S

Wed, 13 Jul 2011 12:00:00 GMT

Dr. Igor Fisch has been elected to Affitech’s board of directors

(PRWeb July 13, 2011)

Read the full story at http://www.prweb.com/releases/2011/7/prweb8635364.htm

Selexis SA CEO to Speak at the GEN Drug Discovery Theater at BIO 2011

Tue, 28 Jun 2011 08:00:00 GMT

Dr. Igor Fisch to Present Data on Company’s New Designer CHO Cell Lines Developed to Overcome Protein Expression Bottlenecks Associated with Hard-to-express Proteins

(PRWeb June 28, 2011)

Read the full story at http://www.prweb.com/releases/drug_development/protein_antibody/prweb8605691.htm

Selexis SA to Give Away € 25,000 SUREvariant Screening Service Project at BIO 2011

Fri, 24 Jun 2011 16:05:00 GMT

Celebrating Launch of New Service in Support of Biologic Lead Identification

(PRWeb June 24, 2011)

Read the full story at http://www.prweb.com/releases/monoclonal_antibodies/bio_selexis/prweb8599244.htm

BioXpress Therapeutics SA to Partner the 2011 BIO International Convention

Wed, 15 Jun 2011 07:00:00 GMT

BioXpress Therapeutics to Meet with Companies Interested in Monoclonal Antibody Biosimilars

(PRWeb June 15, 2011)

Read the full story at http://www.prweb.com/releases/biosimilar/monoclonal_antibody/prweb8572589.htm

Selexis SA to Partner and Exhibit at BIO 2011 in Washington DC

Wed, 01 Jun 2011 10:00:00 GMT

Selexis to Meet with Companies Interested in Cell Line Development and Variant Screening Services for Therapeutic Drug Development and Manufacturing

(PRWeb June 01, 2011)

Read the full story at http://www.prweb.com/releases/Selexis_drug_development/BIO_2011/prweb8503892.htm

Selexis SA to Speak on Fc Fusion Proteins at the 2011 European Society for Animal Cell Technology (ESACT) Conference

Wed, 20 Apr 2011 11:00:00 GMT

Fc Fusion Proteins: A Growing Class of Therapeutics

(PRWeb April 20, 2011)

Read the full story at http://www.prweb.com/releases/ESACT_2011/Fc_fusion_proteins/prweb5258744.htm

Selexis SA to Speak on Rapidly Identifying Relevant Monoclonal Antibody Variants at the 2011 Protein Engineering (PEGS) Summit

Tue, 19 Apr 2011 11:00:00 GMT

“Exploiting Potent Chromatin Remodeling Elements to Rapidly Identify Relevant Monoclonal Antibody Variants in Stable CHO Cell Lines”

(PRWeb April 19, 2011)

Read the full story at http://www.prweb.com/releases/protein_engineering_PEGS/monoclonal_antibody/prweb5258534.htm

Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome

Wed, 23 Mar 2011 15:00:00 GMT

Major Milestone Will Speed Regulatory Filings for Recombinant Protein Therapeutics and Monoclonal Antibodies Developed with the Proprietary Selexis SURE CHO-M Cell Line

(PRWeb March 23, 2011)

Read the full story at http://www.prweb.com/releases/Selexis/SURECHO-M_Cell_Line/prweb5188424.htm

Selexis SA to Partner at the BIO-Europe Spring 2011 Partnering Conference

Fri, 11 Mar 2011 12:00:00 GMT

Selexis will be participating in the BIO-Europe Spring 2011 Partnering Conference being held March 14-16, 2011, at the Milano Convention Center in Milan, Italy.

(PRWeb March 11, 2011)

Read the full story at http://www.prweb.com/releases/2011/03/prweb5153124.htm

Selexis SA Celebrates 10 Years of Innovative Technologies for Mammalian Cells Lines Used in Protein Manufacturing

Wed, 09 Mar 2011 16:00:00 GMT

Selexis SA, a Swiss-based biotechnology company with technologies for the rapid development and engineering of high yield and stable mammalian cell lines for therapeutic protein manufacturing of recombinant drugs celebrated its 10-Year Anniversary today.

(PRWeb March 09, 2011)

Read the full story at http://www.prweb.com/releases/2011/03/prweb5143394.htm

Selexis SA Launches the SURE Variant Screening™ Service

Tue, 08 Mar 2011 16:00:00 GMT

New Service Will Speed Library Screening Campaigns

(PRWeb March 08, 2011)

Read the full story at http://www.prweb.com/releases/Selexis_variant_screening/03082011/prweb5140484.htm

Selexis SA Doubles Cell Line Development Laboratory Space in Geneva, Switzerland

Wed, 09 Feb 2011 14:00:00 GMT

Major Expansion Includes Protein Purification Unit

(PRWeb February 09, 2011)

Read the full story at http://www.prweb.com/releases/selexis/cell_line_development/prweb5048214.htm